Imprinting defects in osteosarcoma: DNA- and chromatin-modifying drugs hold promise for osteosarcoma therapy

Anne E. Sarver, Subbaya Subramanian

Research output: Contribution to journalReview article

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)885-888
Number of pages4
JournalEpigenomics
Volume8
Issue number7
DOIs
StatePublished - Jul 2016

Keywords

  • 14q32-locus
  • DNA methylation
  • chromatin modifying drugs
  • epigenomics
  • imprinting
  • miRNA
  • osteosarcoma

Cite this